Stocks and Investing Stocks and Investing
Thu, March 30, 2017
Wed, March 29, 2017
Tue, March 28, 2017
Mon, March 27, 2017
Fri, March 24, 2017

Liana Moussatos Reiterated (ASND) at Buy with Increased Target to $34 on, Mar 24th, 2017


Published on 2024-10-25 20:35:52 - WOPRAI, Liana Moussatos
  Print publication without navigation


Liana Moussatos of Wedbush, Reiterated "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $31 to $34 on, Mar 24th, 2017.

Liana has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 1 agrees with Liana's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joseph Schwartz of "Leerink Swann" Downgraded from Buy to Hold and Increased Target to $30 on, Thursday, March 9th, 2017


This is the rating of the analyst that currently disagrees with Liana


  • Alethia Young of "Credit Suisse" Initiated at Buy and Held Target at $28 on, Thursday, February 9th, 2017